MedPath

Effect of Nurse Navigation Program on Cervical Cancer Screening Behaviour of the Women Aged 30-65

Not Applicable
Conditions
Cervical Cancers
Registration Number
NCT06647992
Lead Sponsor
TURKAN OZDAS
Brief Summary

This study was designed as a randomized controlled experimental study to examine the effect of the 'Nurse Navigation Program' on cervical cancer screening behaviors (Human Papilloma Virus (HPV) DNA screening test and/or pap smear test) and health beliefs about cervical cancer screening in women aged 30-65 years.

Detailed Description

An important step in the fight against cervical cancer is access to early diagnosis, early screening culture and the creation of screening opportunities. Problems in access to health services, barriers and cultural reasons play an important role in participation in cervical cancer screening. Nurse The Navigation Program is important to help individuals overcome and cope with these barriers. There are international studies showing the positive effect of the nurse navigation program on cervical cancer screening behaviors. However, it is thought that this study will contribute to the literature because the number of studies on this subject is not sufficient and no research is found in national sources.

It is aimed to contribute to overcoming the problems and obstacles in front of the patients' access to cervical cancer screening with the Nurse Navigation Program application developed based on the Transtheoretical Model to the experimental group and to provide evidence for the nurse navigation program application to be a method used in the cervical cancer screening process.

The population of the study will consist of female members of Non-Governmental Organizations in the 30-65 age group. The data of the study will be collected between September 13, 2024 and February 15, 2025 after ethics committee approval and institutional permission. The design of the study is a randomized controlled experimental study.

The data will be collected using the Individual Descriptive Information Form, Information Questions on Reproductive Health and Sexual Life, Questions on Cervical Cancer and Screening, Questions on HPV Knowledge, Cervical Cancer and Pap Smear Test Health Belief Model Scale. The statistical data obtained as a result of the research will be analyzed using the SPSS package program. It is expected that the rate of having HPV-DNA test and Pap smear test is higher in the experimental group in which the nurse navigation program is applied compared to the control group in which the intervention is not applied, and the mean score of benefit perception of cervical cancer screening behaviors (HPV DNA and/or Pap smear) is expected to be significantly different in the group in which the nurse navigation program is applied compared to the group in which it is not applied.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • 30-65 years old,
  • With health insurance,
  • No history of gynecologic cancer,
  • Current or past active sexual life
  • Women who agreed to participate in the study
Exclusion Criteria
  • Diagnosed with gynecologic cancer,
  • The one who had a hysterectomy,
  • Who do not want to be involved in the study,
  • No previous sexual experience,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Health Belief Model Scale for Cervical Cancer and Pap Smear Test: Psychometric testingPre-test, 3rd month post-test, 6th month post-test

Health Belief Model Scale for Cervical Cancer and Pap Smear Test: Psychometric testing consists of 35 items grouped into five subscales.

1. Pap smear Benefit (items 18.-22.) and Health Motivation (items 11.-14.) subscales

2. Pap smear Perception of obstacle (items 23-36) subscale,

3. Cervical cancer severity perception (Items 4-10) subscale,

4. Cervical cancer sensitivity perception (Items 1 - 3) subscale,

5. Health Motivation subscale (items 15-17) A 5-point Likert scale ranging from 1 to 5 - "strongly disagree" (1), "disagree" (2), "undecided" (3), "agree" (4), "strongly agree" (5) - was used to assess the scale. Each dimension of the scale is evaluated separately and not combined into a single total score. For each individual, as many points are obtained as the number of sub-dimensions.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Saglık Bilimleri University

🇹🇷

Istanbul, Üsküdar, Turkey

© Copyright 2025. All Rights Reserved by MedPath